LVMH Moet Hennessy-Louis Vuitton SE Acquisition of Tiffany & Co.

Dr. Frys specializes in the application of market design, microeconomic, and statistical principles to antitrust disputes, litigation, and arbitration. He has analyzed economic and statistical issues and helped draft reports in cases involving vertical and horizontal mergers, cartels, abuse of dominance, and retail price maintenance. Dr. Frys’s experience spans industries such as retail, agriculture, food processing, payment systems, waste and water management, energy, luxury goods, and technology. He has supported experts before multiple authorities and courts, including the French Competition Authority (FCA), the European Commission Directorate-General for Competition (DG COMP), the Tribunal of Commerce of Paris, the International Chamber of Commerce (ICC) International Court of Arbitration, and the Düsseldorf court of appeal. Prior to joining Analysis Group, Dr. Frys assisted the French government in developing an algorithm to assign French first-year students to universities.

Mr White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal and the Amsterdam District Court on competition cases.

Mr White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission (EC), including on behalf of clients involved in cartel investigations, abuse of dominance investigations and mergers. Mr White has also provided support to European financial and competition regulators in coordinated conduct investigations.

Mr White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration and competition from generic manufacturers.

Mr White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.